Nurses are well positioned to stop dangerous and costly bloodstream infections caused by the improper placement of catheters in large veins in the neck, chest or groin, according to guidelines released by the Joint Commission, which oversees accreditation for U.S. hospitals, nursing homes and other healthcare facilities. Central line-associated bloodstream infections (CLABSI) needlessly afflict thousands of patients each year, lengthening hospital stays, boosting hospital readmission rates, and driving up the cost of care.
These devastating bloodstream infections dont need to happen, says Patricia Stone, PhD, MPH, RN, FAAN, the Centennial Professor of Health Policy in Nursing at Columbia University School of Nursing. Stone contributed to the best-practice guidelines issued by the Joint Commission and has published extensive research on the prevention of bloodstream infections.
Nurses are on the front lines and can take advantage of their constant contact with patients and other caregivers to explain infection control techniques and help health facilities develop and enforce standards of care that have been proven effective against CLABSI, she says.
Catheters deliver life-saving medicines and nutrients to some of the most vulnerable patients including premature babies in intensive care units, adults recovering from major trauma and surgery, and frail elderly patients in long-term care settings. Without proper insertion, utilization, and maintenance, catheters can also transmit deadly infections to the bloodstream.
Nurses, using their infection control training, play a vital role in creating a culture of patient safety, Stone says. They often help organize and implement effective prevention techniques including catheter insertion checklists, regular replacement of dressings, and proper handwashing techniques. With their background in education, nurses have the knowledge to inform patients and colleagues about evidence-based practices to reduce CLABSI.
Each year in the U.S., there are an estimated 100,000 deaths from healthcare-associated infections, and one third of the fatalities are from CLABSI, according to the Joint Commission.
Healthcare-associated infections create approximately $33 billion in excess medical costs for U.S. hospitals every year, yet it isnt clear how to ensure that best-practices for prevention are followed, Stone found in a review of programs in place at acute-care hospitals that was presented earlier this year at IDWeek, a conference dedicated to research in prevention, diagnosis, treatment and epidemiology of infectious disease. While most hospitals have infection prevention policies, adherence can be haphazard, putting patients at risk, Stone found.
These infections drive up healthcare costs, wasting resources that could be spent meeting so many other patient needs, Stone says. The Joint Commissions guidelines underscore the value of investing in nurses and making sure caregivers at the bedside have all the resources they need to keep patients safe.
Source: Columbia University School of Nursing
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.